Jacob Petersen

2.5k total citations
46 papers, 2.1k citations indexed

About

Jacob Petersen is a scholar working on Genetics, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jacob Petersen has authored 46 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Genetics, 29 papers in Surgery and 21 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jacob Petersen's work include Diabetes and associated disorders (35 papers), Pancreatic function and diabetes (29 papers) and Diabetes Management and Research (16 papers). Jacob Petersen is often cited by papers focused on Diabetes and associated disorders (35 papers), Pancreatic function and diabetes (29 papers) and Diabetes Management and Research (16 papers). Jacob Petersen collaborates with scholars based in Denmark, United States and United Kingdom. Jacob Petersen's co-authors include Thomas Dyrberg, B Michelsen, Allan E. Karlsen, Esper Boel, Ole Madsen, Åke Lernmark, William Hagopian, Matthias G. von Herrath, Michael O. Marshall and Dirk Homann and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Immunity.

In The Last Decade

Jacob Petersen

45 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacob Petersen Denmark 25 1.5k 1.2k 988 540 233 46 2.1k
James Copeman United Kingdom 11 1.2k 0.8× 540 0.4× 357 0.4× 847 1.6× 670 2.9× 13 2.2k
Cristina Costa Spain 21 605 0.4× 770 0.6× 224 0.2× 214 0.4× 691 3.0× 50 1.6k
Yoshiyuki Ban Japan 28 1.2k 0.8× 140 0.1× 1.0k 1.1× 605 1.1× 444 1.9× 53 2.2k
Chaoxing Yang United States 17 370 0.2× 506 0.4× 216 0.2× 271 0.5× 429 1.8× 26 1.2k
S. T. Bennett United Kingdom 10 826 0.6× 473 0.4× 355 0.4× 149 0.3× 449 1.9× 10 1.3k
Masao Nagata Japan 26 924 0.6× 561 0.5× 442 0.4× 527 1.0× 1.3k 5.7× 106 2.7k
H. A. Drexhage Netherlands 23 278 0.2× 186 0.2× 324 0.3× 781 1.4× 151 0.6× 57 1.5k
Carrie S. Dolman United States 17 146 0.1× 124 0.1× 288 0.3× 429 0.8× 393 1.7× 21 1.4k
Marcel P. Keller Switzerland 16 217 0.1× 73 0.1× 207 0.2× 424 0.8× 603 2.6× 33 1.3k
Alan Blair United States 9 671 0.5× 445 0.4× 444 0.4× 143 0.3× 443 1.9× 12 1.2k

Countries citing papers authored by Jacob Petersen

Since Specialization
Citations

This map shows the geographic impact of Jacob Petersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob Petersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob Petersen more than expected).

Fields of papers citing papers by Jacob Petersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob Petersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob Petersen. The network helps show where Jacob Petersen may publish in the future.

Co-authorship network of co-authors of Jacob Petersen

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob Petersen. A scholar is included among the top collaborators of Jacob Petersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob Petersen. Jacob Petersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Denee, Tom, et al.. (2024). Challenges in Value Assessment for One-Time Gene Therapies for Inherited Retinal Diseases: Are We Turning a Blind Eye?. Value in Health. 28(1). 116–124. 1 indexed citations
2.
Weinstein, David A., et al.. (2022). Ketotic hypoglycemia in patients with Down syndrome: an example of extreme citizen science in biomedicine. University of Southern Denmark Research Portal (University of Southern Denmark). 45–45.
3.
Weinstein, David A., et al.. (2021). Ketotic hypoglycemia in patients with Down syndrome. JIMD Reports. 62(1). 70–73. 6 indexed citations
4.
Herrath, Matthias von, Philippe P. Pagni, Kevin L. Grove, et al.. (2019). Case Reports of Pre-clinical Replication Studies in Metabolism and Diabetes. Cell Metabolism. 29(4). 795–802. 31 indexed citations
5.
Rasmussen, Morten Arendt, Sven Pörksen, Jannet Svensson, et al.. (2013). Complex Multi-Block Analysis Identifies New Immunologic and Genetic Disease Progression Patterns Associated with the Residual β-Cell Function 1 Year after Diagnosis of Type 1 Diabetes. PLoS ONE. 8(6). e64632–e64632. 18 indexed citations
6.
Pörksen, Sven, Lotte B. Nielsen, Jesper Johannesen, et al.. (2010). Analyses of the rate of decline in stimulated c-peptide 12 months after diagnosis in children with newly diag-nosed type 1 diabetes. results from the Hvidoere study group on childhood diabetes. Pediatric Diabetes. 1 indexed citations
7.
Færch, Kristine, et al.. (2010). Treatment with a proton pump inhibitor improves glycaemic control in type 2 diabetic patients - a retrospective analysis. Diabetes Research and Clinical Practice. 90(3). e72–e74. 29 indexed citations
8.
Bregenholt, S, et al.. (2003). The Cholera Toxin B Subunit is a Mucosal Adjuvant for Oral Tolerance Induction in Type 1 Diabetes. Scandinavian Journal of Immunology. 57(5). 432–438. 27 indexed citations
9.
Bregenholt, Søren, et al.. (2002). A New Model for Analyzing Immunomodulation of T Cell Responses Induced by Oral Administration of Islet Cell Antigens. Annals of the New York Academy of Sciences. 958(1). 179–181. 3 indexed citations
10.
Hamid, M., Søren Bregenholt, Dale R. Wegmann, et al.. (2002). Genetic fusion of human insulin B‐chain to the B‐subunit of cholera toxin enhances in vitro antigen presentation and induction of bystander suppression in vivo. Immunology. 106(2). 237–245. 27 indexed citations
11.
Batstra, Manou R., Jacob Petersen, G.J. Bruining, et al.. (2001). Low prevalence of GAD and IA2 antibodies in schoolchildren from a village in the southwestern section of The Netherlands. Human Immunology. 62(10). 1106–1110. 13 indexed citations
12.
Homann, Dirk, Andreas Holz, Adrian Bot, et al.. (1999). Autoreactive CD4+ T Cells Protect from Autoimmune Diabetes via Bystander Suppression Using the IL-4/Stat6 Pathway. Immunity. 11(4). 463–472. 159 indexed citations
13.
14.
Plesner, Annette, Anne Worsaae, Thomas Dyrberg, et al.. (1998). Immunization of Diabetes-prone or Non-diabetes-Prone Mice with GAD65 Does Not Induce Diabetes or Islet Cell Pathology. Journal of Autoimmunity. 11(4). 335–341. 18 indexed citations
15.
Kulmala, Petri, K. Savola, Jacob Petersen, et al.. (1998). Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group.. Journal of Clinical Investigation. 101(2). 327–336. 231 indexed citations
16.
Petersen, Jacob, P. Mackay, Annette Plesner, et al.. (1997). Treatment with GAD65 or BSA Does Not Protect Against Diabetes in BB Rats. Autoimmunity. 25(3). 129–138. 8 indexed citations
17.
Lund, Kaare, Jacob Petersen, Jan Jensen, et al.. (1995). Islet expression of Rhombotin and Isl-1 suggests cell type specific exposure of LIM-domain epitopes. Endocrine. 3(6). 399–408. 4 indexed citations
18.
Petersen, Jacob & Thomas Dyrberg. (1992). Production of epitope specific monoclonal IgG antibodies to HLA class II molecules by combining in vivo and in vitro immunization. Journal of Immunological Methods. 151(1-2). 15–26. 5 indexed citations
19.
Thivolet, C., Marcel Tappaz, A. Durand, et al.. (1992). Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of Type 1 (insulin-dependent) diabetes mellitus in high risk individuals. Diabetologia. 35(6). 570–576. 56 indexed citations
20.
Bonnevie‐Nielsen, V., Anne‐Marie Gerdes, Jan Fleckner, et al.. (1991). Interferon Stimulates the Expression of 2′,5′ -Oligoadenylate Synthetase and MHC Class I Antigens in Insulin-Producing Cells. Journal of Interferon Research. 11(5). 255–260. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James Copeman Breakdown of academic impact, for papers by Cristina Costa Breakdown of academic impact, for papers by Yoshiyuki Ban Breakdown of academic impact, for papers by Chaoxing Yang Breakdown of academic impact, for papers by S. T. Bennett Breakdown of academic impact, for papers by Masao Nagata Breakdown of academic impact, for papers by H. A. Drexhage Breakdown of academic impact, for papers by Carrie S. Dolman Breakdown of academic impact, for papers by Marcel P. Keller Breakdown of academic impact, for papers by Alan Blair
Rankless by CCL
2026